Tazeen Ahmad

Stock Analyst at B of A Securities

(0.3)
# 2025
Out of 5,240 analysts
221
Total ratings
39.29%
Success rate
5.73%
Average return
55 Stocks
Name Action Price Target Current % Upside Ratings Updated
Prothena Corp
Maintains: Neutral
26 22
12.65 73.91% 5 Dec 19, 2024
4D Molecular Therape...
Maintains: Buy
79 46
4.86 846.5% 3 Dec 18, 2024
KalVista Pharma
Initiates Coverage On: Buy
22
7.38 198.1% 1 Dec 18, 2024
PepGen
Maintains: Neutral
10 6
2.75 118.18% 2 Nov 18, 2024
Apellis Pharmaceutic...
Maintains: Buy
61 47
27.69 69.74% 6 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
68 90
71.9 25.17% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
9.21 62.87% 5 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
307 314
240.92 30.33% 2 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
48 52
53.94 -3.6% 7 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
11 6
7.46 -19.57% 14 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
175 191
131.53 45.21% 8 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 150
112.44 33.4% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 2
4.04 -50.5% 6 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 29
18.76 54.58% 1 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
76 76
39 94.87% 4 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
535 607
665.84 -8.84% 3 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
25 32
41.76 -23.37% 13 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
166 213
118.71 79.43% 21 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
83 76
40.11 89.48% 6 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
26 22
16.89 30.25% 13 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
1.71 601.75% 1 May 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
1.5 833.33% 2 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
4.54 120.26% 4 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
2 6
1.25 380% 2 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
7.88 90.36% 1 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3
n/a n/a 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 1
1.16 -56.9% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
8 11
16.06 -31.51% 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
36 31
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
7.24 38.12% 6 Jul 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 2
1.71 16.96% 2 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
0.05 13900% 3 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90 20
n/a n/a 2 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
1.01 494.06% 4 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
75 15
11.44 31.12% 3 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
390 60
66 -9.09% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
23
0.03 74900% 2 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
16
1.42 1026.76% 1 Nov 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Oct 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
110
17.2 539.53% 1 Sep 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 20
n/a n/a 2 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13 5
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43
6.28 584.71% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
233 227
n/a n/a 4 Feb 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 3 Sep 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Apr 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
330 300
4.65 6351.61% 1 Nov 2, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 39
n/a n/a 6 Nov 2, 2018